-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A8Bs842JpaPRf4TZgsvwbGLDoMnJVkgK40bBTlthQN1SWefHpryG0E8k4Q9V4g68 Xj0YBYZad7sPixidP4uKSQ== 0001324517-05-000008.txt : 20050611 0001324517-05-000008.hdr.sgml : 20050611 20050610104722 ACCESSION NUMBER: 0001324517-05-000008 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050608 FILED AS OF DATE: 20050610 DATE AS OF CHANGE: 20050610 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Antczak Val R CENTRAL INDEX KEY: 0001324517 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 05888986 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 3/A 1 edgar.xml PRIMARY DOCUMENT X0202 3/A 2005-06-08 2005-04-15 0 0000890465 NPS PHARMACEUTICALS INC NPSP 0001324517 Antczak Val R 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 1 0 0 Snr. V.P. and General Counsel Common Stock 650 D Common Stock 3250 I Spouse Common Stock 400 I Children Kevin J. Ontiveros 2005-06-09 EX-24 2 antczak1.htm POWER OF ATTORNEY

Val R. Antczak





















 April 15, 2005







Securities and Exchange Commission

Attn: Filing Desk

450 Fifth Street, N.W.

Washington, D.C. 20549



Re: NPS Pharmaceuticals, Inc.

File No. 0-23272



Ladies and Gentlemen,



By means of this letter, I authorize Kevin J. Ontiveros or Morgan R. Brown to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock or derivative securities of NPS Pharmaceuticals, Inc. Accordingly, Messrs. Ontiveros and Brown are authorized to sign any Form 3, Form 4, Form 5 or amendment thereto which I am required to file with the same effect as if I had signed them myself.



This authorization shall remain in effect until revoked in writing by me.



Sincerely,







/s/ Val R. Antczak

Val R. Antczak



cc: Kevin J. Ontiveros, Assistant Secretary

NPS Pharmaceuticals, Inc.

383 Colorow Drive

Salt Lake City, Utah 84108

-----END PRIVACY-ENHANCED MESSAGE-----